pdufa.bio
HomeReadouts › August 2027

August 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for August 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← July 2027September 2027 →
9 readouts
SMMT · Aug 2027 (est.)
Ivonescimab: Advanced Head and Neck Squamous Cell Carcinoma
TLX · Aug 2027 (est.)
177Lu-TLX591: Clear Cell Renal Cell Carcinoma (ccRCC)
ARTV · Aug 2027 (est.)
AB-101: Lupus Nephritis - WHO Class III
Awaiting dataupdated 7mo ago
ASND · Aug 2027 (est.)
TransCon CNP: Advanced Solid Tumor
Awaiting dataupdated 4mo ago
RARE · Aug 2027 (est.)
Triheptanoin: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
NVCR · Aug 2027 (est.)
Temozolomide: Adenocarcinoma of Lung
Awaiting data
IONS · Aug 2027 (est.)
ION582: Angelman Syndrome
SMMT · Aug 2027 (est.)
Ivonescimab: Biliary Tract Cancer
TLX · Aug 2027 (est.)
177Lu-TLX591: ccRCC
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).